Beyond Air, Inc.
XAIRNasdaq
$5.58
↑ +0.5%Jul 17 close · end-of-day
Price
1Y↓ -91.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$46.3M
Enterprise Value
$34.7M
P/E
—
P/S
6.0
P/B
7.6
EV/EBITDA
—
PEG
—
FCF Yield
-41.4%
Dividend Yield
—
Revenue (TTM)
$7.7M
Net Income (TTM)
-$33.2M
Free Cash Flow (TTM)
-$19.2M
Gross Margin
3.3%
Operating Margin
-378.2%
Net Margin
-433.0%
ROE
-542.8%
ROIC
—
Debt / Equity
—
Net Cash
$11.6M
Return 1Y
-91.4%
Company profile
Beyond Air, Inc. develops nitric oxide generator and delivery systems. LungFit system is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors.
- CEO
- Steven A. Lisi
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 70
- Headquarters
- New York
- Website
- beyondair.net
Earnings
XAIR Q4 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.9M↑ +65.5%
Diluted EPS-$0.38↓ -311.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $873,000.00 | — | — | $1.2M | $3.7M | $7.7M |
| Gross profit | — | — | -$555,000.00 | -$1.3M | -$1.7M | $252,000.00 |
| Operating income | -$22.2M | -$40.7M | -$52.1M | -$63.0M | -$44.5M | -$29.0M |
| Net income | -$22.9M | -$43.2M | -$55.8M | -$60.2M | -$46.6M | -$33.2M |
| Diluted EPS | — | — | -$1.86 | -$1.82 | -$13.77 | -$4.01 |
| Operating cash flow | -$19.6M | -$23.1M | -$33.0M | -$56.0M | -$38.2M | -$18.1M |
| Free cash flow | -$20.5M | -$24.5M | -$36.9M | -$61.8M | -$44.1M | -$19.2M |
| Gross margin | — | — | — | -112.8% | -44.9% | 3.3% |
| Operating margin | -2544.6% | — | — | -5436.2% | -1202.1% | -378.2% |
| Net margin | -2620.3% | — | — | -5197.8% | -1258.4% | -433.0% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $683,000.00 | $798,000.00 | $1.1M | $1.2M | $1.8M | $1.8M | $2.2M | $1.9M |
| Gross profit | -$332,000.00 | -$1.1M | -$215,000.00 | -$32,000.00 | $156,000.00 | -$298,000.00 | $300,000.00 | $94,000.00 |
| Operating income | -$13.6M | -$12.8M | -$11.0M | -$7.2M | -$7.6M | -$7.7M | -$6.6M | -$7.2M |
| Net income | -$12.2M | -$13.4M | -$13.0M | -$8.0M | -$7.7M | -$7.9M | -$7.3M | -$10.3M |
| Diluted EPS | -$5.32 | -$5.67 | -$2.96 | $0.18 | -$1.53 | -$1.25 | -$0.85 | -$0.38 |
| Operating cash flow | -$10.2M | -$13.3M | -$7.7M | -$7.0M | -$4.5M | -$4.5M | -$4.2M | -$4.9M |
| Free cash flow | -$12.9M | -$14.5M | -$8.3M | -$8.5M | -$4.7M | -$4.7M | -$4.3M | -$5.5M |
| Gross margin | -48.6% | -135.8% | -20.1% | -2.8% | 8.9% | -16.4% | 13.7% | 4.9% |
| Operating margin | -1988.3% | -1608.1% | -1021.6% | -622.6% | -432.8% | -421.4% | -300.6% | -376.0% |
| Net margin | -1786.4% | -1673.9% | -1215.7% | -697.4% | -437.0% | -436.7% | -334.4% | -539.2% |
Company news
Jun 26, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.